We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
320 result(s) found, displaying 271 to 280
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Fremanezumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Teva Pharma Australia Pty Ltd - Injector, medication/vaccine, syringe.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROLIMUS-TEVA everolimus 5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROLIMUS-TEVA everolimus 2.5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROLIMUS-TEVA everolimus 10 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVEROLIMUS-TEVA everolimus 7.5 mg tablet blister pack.
-
Prescription medicine registrationActive ingredients: fremanezumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DUORESP SPIROMAX budesonide / formoterol fumarate dihydrate 400 microgram / 12 microgram powder for inhalation dry powder inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DUORESP SPIROMAX budesonide / formoterol fumarate dihydrate 200 microgram / 6 microgram powder for inhalation dry powder inhaler.